Sign Up
Stories
BBS-Bioactive Bone Substitutes Plc's CE Marking Progress
Share
Osteoporosis Scanning Crisis
Overview
API
BBS-Bioactive Bone Substitutes Plc, an orthobiology company, is on the verge of obtaining CE marking for its first product, ARTEBONE Paste. The approval process for the quality system is expected to take 3-7 months, while preliminary commercialization measures are already underway. The company has received an audit report from the Notified Body, with a plan for the completion of minor open measures to be submitted within two weeks.
Ask a question
How does BBS-Bioactive Bone Substitutes Plc's mission align with the broader healthcare industry trends and advancements?
How might the successful obtaining of CE marking for ARTEBONE Paste impact BBS-Bioactive Bone Substitutes Plc's market presence and potential expansion?
What challenges might BBS-Bioactive Bone Substitutes Plc face during the CE marking process and how might they address them?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Apr 2023
May 2023
Jun 2023
Jul 2023
Aug 2023
Coverage